$3.29 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 274 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OCX | ONCOCYTE CORP | $43,517,000 | -38.0% | 12,223,953 | 0.0% | 1.32% | -39.4% | |
| FULGENT GENETICS INCput | $8,995,000 | -2.5% | 100,000 | 0.0% | 0.27% | -4.5% | ||
| CYTOKINETICS INCnote 4.000%11/1 | $8,849,000 | +70.9% | 25,000 | 0.0% | 0.27% | +67.1% | ||
| DECIPHERA PHARMACEUTICALS INcall | $3,388,000 | -7.2% | 99,700 | 0.0% | 0.10% | -9.6% | ||
| SPKBU | SILVER SPIKE ACQUISITN CORPunit 02/26/2026 | $777,000 | -0.8% | 77,505 | 0.0% | 0.02% | 0.0% | |
| GOSSAMER BIO INCnote 5.000% 6/0 | $522,000 | +29.2% | 5,000 | 0.0% | 0.02% | +23.1% | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $238,000 | +14.4% | 22,603 | 0.0% | 0.01% | +16.7% | |
| MAPSW | WM TECHNOLOGY INC*w exp 06/16/202 | $216,000 | -32.1% | 50,000 | 0.0% | 0.01% | -30.0% | |
| TCACU | TUATARA CAPITAL ACQUISITN COunit 99/99/9999 | $200,000 | -2.0% | 20,000 | 0.0% | 0.01% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.